Details for Patent: 9,555,027
✉ Email this page to a colleague
Which drugs does patent 9,555,027 protect, and when does it expire?
Patent 9,555,027 protects LATUDA and is included in one NDA.
This patent has thirty-five patent family members in twenty-two countries.
Summary for Patent: 9,555,027
| Title: | Pharmaceutical composition |
| Abstract: | A preparation for oral administration comprising: a pregelatinized starch comprising N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-(2R,3R)-2,3-tetramethyle- ne-butyl]-(1'R,2'S,3'R,4'S)-2,3-bicyclo[2,2,1]-heptanedicarboxyimide hydrochloride (lurasidone) represented by the formula (1) as an active ingredient; a water-soluble excipient; and a water-soluble polymeric binder, the preparation exhibiting an invariant level of elution behavior even when the content of its active ingredient is varied. |
| Inventor(s): | Fujihara; Kazuyuki (Suzuka, JP) |
| Assignee: | SUMITOMO DAINIPPON PHARMA CO., LTD. (Osaka, JP) |
| Application Number: | 14/512,189 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,555,027 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Compound; Process; Dosage form; |
Drugs Protected by US Patent 9,555,027
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-003 | Dec 7, 2011 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF SCHIZOPHRENIA | ⤷ Sign Up | ||
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-001 | Oct 28, 2010 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF SCHIZOPHRENIA | ⤷ Sign Up | ||
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-005 | Jul 12, 2013 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF SCHIZOPHRENIA | ⤷ Sign Up | ||
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-002 | Oct 28, 2010 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF SCHIZOPHRENIA | ⤷ Sign Up | ||
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-004 | Apr 26, 2012 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF SCHIZOPHRENIA | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,555,027
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Japan | 2005-153508 | May 26, 2005 |
International Family Members for US Patent 9,555,027
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1884242 | ⤷ Sign Up | 92550 | Luxembourg | ⤷ Sign Up |
| European Patent Office | 1884242 | ⤷ Sign Up | C300690 | Netherlands | ⤷ Sign Up |
| European Patent Office | 1884242 | ⤷ Sign Up | CA 2014 00049 | Denmark | ⤷ Sign Up |
| European Patent Office | 1884242 | ⤷ Sign Up | PA2014034 | Lithuania | ⤷ Sign Up |
| European Patent Office | 1884242 | ⤷ Sign Up | C20140030 00118 | Estonia | ⤷ Sign Up |
| European Patent Office | 1884242 | ⤷ Sign Up | 1490057-5 | Sweden | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
